| 000 | 01869 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250518074954.0 | ||
| 264 | 0 | _c20210422 | |
| 008 | 202104s 0 0 eng d | ||
| 022 | _a1582-4934 | ||
| 024 | 7 |
_a10.1111/jcmm.14867 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZalles, Michelle | |
| 245 | 0 | 0 |
_aOptimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model. _h[electronic resource] |
| 260 |
_bJournal of cellular and molecular medicine _c01 2020 |
||
| 300 |
_a1738-1749 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aChickens |
| 650 | 0 | 4 |
_aGlioblastoma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMicrovessels _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _ximmunology |
| 650 | 0 | 4 |
_aReceptors, Notch _xmetabolism |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aSmith, Nataliya | |
| 700 | 1 | _aZiegler, Jadith | |
| 700 | 1 | _aSaunders, Debra | |
| 700 | 1 | _aRemerowski, Shannon | |
| 700 | 1 | _aThomas, Lincy | |
| 700 | 1 | _aGulej, Rafal | |
| 700 | 1 | _aMamedova, Nadya | |
| 700 | 1 | _aLerner, Megan | |
| 700 | 1 | _aFung, Kar-Ming | |
| 700 | 1 | _aChung, Junho | |
| 700 | 1 | _aHwang, Kyusang | |
| 700 | 1 | _aJin, Junyeong | |
| 700 | 1 | _aWiley, Graham | |
| 700 | 1 | _aBrown, Chase | |
| 700 | 1 | _aBattiste, James | |
| 700 | 1 | _aWren, Jonathan D | |
| 700 | 1 | _aTowner, Rheal A | |
| 773 | 0 |
_tJournal of cellular and molecular medicine _gvol. 24 _gno. 2 _gp. 1738-1749 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jcmm.14867 _zAvailable from publisher's website |
| 999 |
_c30446525 _d30446525 |
||